Detalhe da pesquisa
1.
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Circulation
; 143(6): 516-525, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186500
2.
Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF).
Circulation
; 146(4): 364-367, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877829
3.
The impact of COVID-19 on the management of heart failure: a United Kingdom patient questionnaire study.
ESC Heart Fail
; 8(2): 1324-1332, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33463044
4.
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
JAMA Cardiol
; 6(10): 1130-1143, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34160566
5.
Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations.
Open Heart
; 8(1)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637568
6.
Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome.
Circ Cardiovasc Interv
; 12(8): e007830, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362541
7.
Approaches to the treatment of anaemia in patients with chronic heart failure.
Heart Fail Rev
; 13(4): 431-8, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18392791